Wellington Management Group’s AMAG Pharmaceuticals AMAG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-39,654
Closed -$794K 2269
2018
Q3
$794K Sell
39,654
-28,596
-42% -$651K ﹤0.01% 1938
2018
Q2
$1.33M Buy
68,250
+54,749
+406% +$1.21M ﹤0.01% 1824
2018
Q1
$272K Buy
+13,501
New +$228K ﹤0.01% 2123
2017
Q3
Sell
-52,037
Closed -$957K 2328
2017
Q2
$957K Sell
52,037
-109,702
-68% -$2.17M ﹤0.01% 1889
2017
Q1
$3.65M Buy
161,739
+113,240
+233% +$2.71M ﹤0.01% 1549
2016
Q4
$1.69M Buy
+48,499
New +$1.45M ﹤0.01% 1735
2015
Q2
Sell
-192,626
Closed -$10.5M 2258
2015
Q1
$10.5M Sell
192,626
-56,235
-23% -$2.68M ﹤0.01% 1227
2014
Q4
$10.6M Sell
248,861
-79,079
-24% -$2.86M ﹤0.01% 1224
2014
Q3
$10.5M Buy
327,940
+1,880
+0.6% +$40.1K ﹤0.01% 1226
2014
Q2
$6.76M Buy
326,060
+34,300
+12% +$634K ﹤0.01% 1367
2014
Q1
$5.64M Sell
291,760
-54,392
-16% -$1.16M ﹤0.01% 1415
2013
Q4
$8.4M Buy
346,152
+29,922
+9% +$704K ﹤0.01% 1296
2013
Q3
$6.79M Sell
316,230
-38,000
-11% -$898K ﹤0.01% 1344
2013
Q2
$7.88M Buy
+354,230
New +$7.81M ﹤0.01% 1265

Other funds holding AMAG

Wellington Management Group's AMAG Position: Q4 2018 in Review

Wellington Management Group sold out of AMAG Pharmaceuticals (AMAG) in Q4 2018, closing a stake of 39,654 shares — an estimated $794K sold.

Wellington Management Group first reported a position in AMAG in Q2 2013 and held it in 14 quarters. The position peaked at $10.6M in Q4 2014. 190 funds tracked by Wall St. Rank hold AMAG as of Q4 2018.

  • Wellington Management Group reported no remaining AMAG Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Wellington Management Group sold 39,654 AMAG Pharmaceuticals shares in Q4 2018, an estimated $794K.
  • Wellington Management Group first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 14 quarters.
  • Wellington Management Group's AMAG Pharmaceuticals position peaked at $10.6M in Q4 2014.
  • 190 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2018.

Based on Wellington Management Group's 13F filing for Q4 2018, filed 14 Feb 2019.